Orbital inflammatory disease following mRNA SARS‐CoV‐2 vaccine

Solange Grunenwald; Gabriel Lethellier; Philippe Imbert; Céline Dekeister; Philippe Caron

doi:10.1002/ccr3.5926

Clinical Case Reports (Jun 2022)

Orbital inflammatory disease following mRNA SARS‐CoV‐2 vaccine

Solange Grunenwald,
Gabriel Lethellier,
Philippe Imbert,
Céline Dekeister,
Philippe Caron

Affiliations

Solange Grunenwald: Multidisciplinary Thyroid‐Eye Outpatient Clinic Department of Endocrinology and Metabolic Disease Cardio‐Vascular and Metabolic Unit CHU Larrey (University Hospital Centre) Toulouse France
Gabriel Lethellier: Department of Ophthalmology CH intercommunal Castres‐Mazamet Castres France
Philippe Imbert: Multidisciplinary Thyroid‐Eye Outpatient Clinic Department of Endocrinology and Metabolic Disease Cardio‐Vascular and Metabolic Unit CHU Larrey (University Hospital Centre) Toulouse France
Céline Dekeister: Multidisciplinary Thyroid‐Eye Outpatient Clinic Department of Endocrinology and Metabolic Disease Cardio‐Vascular and Metabolic Unit CHU Larrey (University Hospital Centre) Toulouse France
Philippe Caron: Multidisciplinary Thyroid‐Eye Outpatient Clinic Department of Endocrinology and Metabolic Disease Cardio‐Vascular and Metabolic Unit CHU Larrey (University Hospital Centre) Toulouse France

DOI: https://doi.org/10.1002/ccr3.5926
Journal volume & issue: Vol. 10, no. 6
pp. n/a – n/a

Abstract

Read online

Abstract A 65‐year‐old woman reported orbital symptoms two days after her first dose and presented exacerbation of signs after the second dose of BNT162b2 mRNA vaccine. The temporal relationship between the COVID‐19 vaccination and orbital symptoms suggests a probable link between SARS‐CoV‐2 mRNA vaccine and this orbital inflammatory disease.

Published in Clinical Case Reports

ISSN: 2050-0904 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Medicine (General)
Website: https://onlinelibrary.wiley.com/journal/20500904

About the journal

Abstract

Keywords